We are live on
!
Find out more
JAM
JW Asset Management Portfolio holdings
AUM
$244M
1-Year Est. Return
71.51%
This Fund
S&P 500
This Quarter
Est. Return
+8.14%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$210M
AUM Growth
-$11.1M
(-5%)
Cap. Flow
-$25M
Cap. Flow
% of AUM
-11.9%
Top 10 Holdings %
Top 10 Hldgs %
97.77%
Holding
19
New
6
Increased
–
Reduced
3
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BTC
Grayscale Bitcoin Mini Trust ETF
BTC
|
+$3.94M |
| 2 |
Amazon
AMZN
|
+$2.97M |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.88M |
| 4 |
Robinhood
HOOD
|
+$323K |
| 5 |
OKLO
Oklo
OKLO
|
+$291K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$20.7M |
| 2 |
AdvisorShares Pure US Cannabis ETF
MSOS
|
+$7.84M |
| 3 |
Establishment Labs
ESTA
|
+$4.36M |
| 4 |
Idaho Strategic Resources
IDR
|
+$1.48M |
| 5 |
BBBY
Bed Bath & Beyond
BBBY
|
+$302K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 74.5% |
| 2 | Technology | 9.08% |
| 3 | Consumer Discretionary | 7.1% |
| 4 | Consumer Staples | 5.19% |
| 5 | Communication Services | 0.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Establishment Labs
ESTA
$2.7B
| $142M | 67.72% |
3,092,485
-100,000
| -3% | -$4.36M |
|
|
2
NVIDIA
NVDA
$4.77T
| $19.1M | 9.08% |
142,250
-150,000
| -51% | -$20.7M |
|
3
Vita Coco
COCO
$3.97B
| $10.9M | 5.19% |
295,621
| – | – |
|
4
Abercrombie & Fitch
ANF
$4.58B
| $9.73M | 4.62% |
65,090
| – | – |
|
|
CPRX
5
DELISTED
Catalyst Pharmaceutical
CPRX
| $8.63M | 4.1% |
413,392
| – | – |
|
|
BTC
6
Grayscale Bitcoin Mini Trust ETF
BTC
$3.38B
| $4.48M | 2.13% |
+107,000
| New | +$3.94M |
|
7
Heron Therapeutics
HRTX
$92M
| $3.51M | 1.67% |
2,292,418
| – | – |
|
|
8
Amazon
AMZN
$2.48T
| $3.18M | 1.51% |
+14,500
| New | +$2.97M |
|
|
9
Meta Platforms (Facebook)
META
$1.51T
| $1.87M | 0.89% |
+3,200
| New | +$1.88M |
|
10
Viking Therapeutics
VKTX
$3.93B
| $1.81M | 0.86% |
45,000
| – | – |
|
|
11
Idaho Strategic Resources
IDR
$456M
| $1.65M | 0.78% |
161,697
-110,000
| -40% | -$1.48M |
|
12
Alibaba
BABA
$276B
| $1.27M | 0.6% |
15,000
| – | – |
|
13
Five Below
FIVE
$11.5B
| $525K | 0.25% |
5,000
| – | – |
|
|
14
Robinhood
HOOD
$83.3B
| $373K | 0.18% |
+10,000
| New | +$323K |
|
|
OKLO
15
Oklo
OKLO
$6.89B
| $318K | 0.15% |
+15,000
| New | +$291K |
|
|
HITI
16
High Tide
HITI
$181M
| $316K | 0.15% |
102,144
| – | – |
|
|
GAP
17
The Gap Inc
GAP
$7.28B
| $236K | 0.11% |
+10,000
| New | +$228K |
|
|
BBBY
18
Bed Bath & Beyond
BBBY
$503M
| – | – |
-33,000
| Closed | -$302K |
|
|
19
AdvisorShares Pure US Cannabis ETF
MSOS
$830M
| – | – |
-1,093,369
| Closed | -$7.84M |
|
Similar funds
SC
HCM
SC
HBS
GIM
IFO
VG
CP
JW Asset Management's Q4 2024 Portfolio in Review
As of Q4 2024, JW Asset Management held 19 positions worth $210M, down 5% from $221M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
JW Asset Management withdrew a net $25M in Q4 2024, closing 2 positions and reducing 3 holdings. Its most notable exit was AdvisorShares Pure US Cannabis ETF, an estimated $7.84M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 74% of assets, up from 70% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, JW Asset Management opened a new position in Grayscale Bitcoin Mini Trust ETF worth $4.48M.
- JW Asset Management's largest Q4 2024 buy was Grayscale Bitcoin Mini Trust ETF: 107,000 shares worth $4.48M.
- JW Asset Management's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $20.7M.
- JW Asset Management fully exited AdvisorShares Pure US Cannabis ETF in Q4 2024, selling an estimated $7.84M.
- JW Asset Management's ten largest holdings make up 98% of its $210M portfolio in Q4 2024.
- JW Asset Management opened 6 new positions and closed 2 in Q4 2024.
- JW Asset Management's portfolio value fell 5% quarter-over-quarter to $210M.
Based on JW Asset Management's 13F filing for Q4 2024, filed 7 Feb 2025.